Vima LLC’s AbbVie ABBV Stock Holding History

Vima LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20.9K	Hold	80	–	–	0.02%	212
2026 Q2	$20.1K	Buy	+80	New	+$17.2K	0.02%	221

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Vima LLC's ABBV Position: Q3 2026 in Review

Vima LLC held its AbbVie (ABBV) position steady in Q3 2026 at 80 shares worth $20.9K. The position accounts for 0.02% of the portfolio, ranked #212.

Vima LLC first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 2,106 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Vima LLC held 80 shares of AbbVie worth $20.9K as of Q3 2026.
Vima LLC left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.02% of Vima LLC's portfolio in Q3 2026, its #212 holding.
Vima LLC first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
2,106 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vima LLC's 13F filing for Q3 2026, filed 23 Oct 2026.